Free Trial

Short Interest in Zepp Health Corporation Sponsored ADR (NYSE:ZEPP) Grows By 157.6%

Zepp Health logo with Medical background

Key Points

  • Short interest in Zepp Health Corporation rose by 157.6% in July, reaching a total of 308,600 shares from 119,800 shares in June.
  • Analysts from Fundamental Research set a $13.87 price objective for Zepp Health and rated the stock as a "buy."
  • The company's recent quarterly earnings showed a loss of ($1.13) per share with a revenue of $38.54 million.
  • MarketBeat previews top five stocks to own in September.

Zepp Health Corporation Sponsored ADR (NYSE:ZEPP - Get Free Report) was the recipient of a significant growth in short interest in July. As of July 15th, there was short interest totaling 308,600 shares, agrowthof157.6% from the June 30th total of 119,800 shares. Based on an average trading volume of 453,900 shares, the days-to-cover ratio is presently 0.7 days. Approximately4.4% of the shares of the stock are short sold. Approximately4.4% of the shares of the stock are short sold. Based on an average trading volume of 453,900 shares, the days-to-cover ratio is presently 0.7 days.

Wall Street Analysts Forecast Growth

Separately, Fundamental Research set a $13.87 price objective on Zepp Health and gave the stock a "buy" rating in a research note on Tuesday, April 22nd.

Get Our Latest Stock Analysis on Zepp Health

Zepp Health Stock Performance

Zepp Health stock opened at $12.98 on Monday. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.14 and a quick ratio of 0.84. The stock has a fifty day moving average price of $5.87 and a two-hundred day moving average price of $3.88. Zepp Health has a 52-week low of $2.06 and a 52-week high of $15.85. The firm has a market capitalization of $188.21 million, a P/E ratio of -2.59 and a beta of 1.11.

Zepp Health (NYSE:ZEPP - Get Free Report) last released its quarterly earnings data on Monday, May 19th. The company reported ($1.13) earnings per share (EPS) for the quarter. Zepp Health had a negative return on equity of 23.60% and a negative net margin of 44.54%. The company had revenue of $38.54 million for the quarter.

About Zepp Health

(Get Free Report)

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Zepp Health Right Now?

Before you consider Zepp Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zepp Health wasn't on the list.

While Zepp Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines